comparemela.com
Latest Breaking News On - Iv choline chloride program - Page 1 : comparemela.com
Protara Therapeutics Announces Third Quarter 2023 Financial Results and Business Update
Dosing is progressing well in ADVANCED-1EXP trial evaluating TARA-002 in NMIBC patients with CIS; preliminary results expected in 1H24Company init.
Germany
Taiwan
Japan
United-states
German
Jesse-shefferman
Klinische-einheit
Justine-omalley
Exchange-commission
Protara-therapeutics-inc
Iv-choline-chloride-program
Chugai-pharmaceutical-co-ltd
vimarsana © 2020. All Rights Reserved.